However, one study revealed that fingolimod increased stress resilience (i.e., prevented stress-evoked depression-like behavior) in a model of chronic unpredictable stress via activation of S1PR3 in the medial prefrontal cortex [19, 21]. This evidence concerns the gene S1PR3 and major depressive disorder.